FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alastair Glendenning

Research Profile

Concepts & Ideas

Chemicals & Drugs

Disorders

Procedures

Activities & Behaviors

Co-author Network

Publications

TOP 3
Stephen P McKenna; David M Meads; Robin Pokrzywinski; Dennis Revicki; James Twiss; Lynda Doward; Cameron J Hunter; G Alastair Glendenning
Development and validation of the living with chronic obstructive pulmonary disease questionnaire.
David M Meads; Stephen P McKenna; Lynda Doward; Robin Pokrzywinski; Dennis Revicki; Cameron Hunter; G Alastair Glendenning
Development and validation of the Asthma Life Impact Scale (ALIS).
Marsha Treadwell; Amy W Law; Jennifer Sung; Ekua Hackney-Stephens; Keith Quirolo; Eileen Murray; G Alastair Glendenning; Elliott Vichinsky
Barriers to adherence of deferoxamine usage in sickle cell disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alastair Glendenning (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Stephen P McKenna; David M Meads; Robin Pokrzywinski; Dennis Revicki; James Twiss; Lynda Doward; Cameron J Hunter; G Alastair Glendenning
Development and validation of the living with chronic obstructive pulmonary disease questionnaire.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2011;20(7):1043-52.
2010: David M Meads; Stephen P McKenna; Lynda Doward; Robin Pokrzywinski; Dennis Revicki; Cameron Hunter; G Alastair Glendenning
Development and validation of the Asthma Life Impact Scale (ALIS).
Respiratory medicine 2010;104(5):633-43.
2005: Marsha Treadwell; Amy W Law; Jennifer Sung; Ekua Hackney-Stephens; Keith Quirolo; Eileen Murray; G Alastair Glendenning; Elliott Vichinsky
Barriers to adherence of deferoxamine usage in sickle cell disease.
Pediatric blood & cancer 2005;44(5):500-7.
2005: Kevin P Weinfurt; Y Li; Liana D Castel; Fred Saad; Justin W Timbie; G Alastair Glendenning; Kevin Schulman
The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):579-84.
2005: Kathleen J Yost; Mark V Sorensen; Elizabeth A Hahn; G Alastair Glendenning; Ari Gnanasakthy; David Cella
Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2005;8(2):117-27.
2005: Shelby D Reed; Jasmina I Radeva; G Alastair Glendenning; Robert E Coleman; Kevin Schulman
Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma.
American journal of clinical oncology 2005;28(1):8-16.
2004: Shelby D Reed; Kevin J Anstrom; Jennifer A Ludmer; G Alastair Glendenning; Kevin Schulman
Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
Cancer 2004;101(11):2574-83.
2004: Kevin J Anstrom; Shelby D Reed; Andrew S Allen; G Alastair Glendenning; Kevin Schulman
Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
Cancer 2004;101(11):2584-92.
2004: Shelby D Reed; Jasmina I Radeva; G Alastair Glendenning; Fred Saad; Kevin Schulman
Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer.
The Journal of urology 2004;171(4):1537-42.
2004: Kevin P Weinfurt; Liana D Castel; Yun Li; Justin W Timbie; G Alastair Glendenning; Kevin Schulman
Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions.
Medical care 2004;42(2):164-75.
2003: Elizabeth A Hahn; G Alastair Glendenning; Mark V Sorensen; Stacie A Hudgens; Brian J Druker; françois guilhot; Richard A Larson; Stephen G O'Brien; Deborah G Dobrez; Martee Hensley; David Cella
Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2138-46.
2003: Elizabeth A Hahn; G Alastair Glendenning
Quality of life on imatinib.
Seminars in hematology 2003;40(2 Suppl 2):31-6.